探索心血管健康前沿| The Journal of Cardiovascular Aging 2024精选文章合集

文摘   2024-12-14 20:37   陕西  

The Journal of Cardiovascular Aging特别推荐2024年以下十篇论文,包括1篇评论文章,1篇社论,4篇原始研究论文和4篇综述文章。这些论文涵盖了心脏细胞增殖、心脏功能与再生、基因组编辑、微血管功能、血管老化防护、心肌细胞衰老治疗、肥胖与心脏淋巴细胞的关联、心衰引发的肌肉减少症、以及克隆性造血的调控和生理后果等多个方面的研究进展。这些研究不仅深入探讨了心血管健康的关键问题,也为未来的心脏疾病治疗提供了新的视角和方法。

所有文章均为开放获取,欢迎各位专家学者免费阅读、下载和分享!

1

JCA

Commentary


1. Fueling cardiac myocyte proliferation

  • Correspondence: Dr. Priyatansh Gurha, Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of Medicine, University of Texas Health Sciences Center at Houston, USA.
  • How to cite: Deogharia M, Gurha P. Fueling cardiac myocyte proliferation. J Cardiovasc Aging. 2024;4:2. 

    http://dx.doi.org/10.20517/jca.2023.47

识别二维码阅读英文全文

2

JCA

Editorial


2. From vitality to vulnerability: the impact of oxygen on cardiac function and regeneration

  • Correspondence: Dr. William T. Pu, Department of Cardiology, Boston Children’s Hospital, USA.

  • How to cite: Yucel D, Pu WT. From vitality to vulnerability: the impact of oxygen on cardiac function and regeneration. J Cardiovasc Aging.

    2024;4:15.http://dx.doi.org/10.20517/jca.2024.05

识别二维码阅读英文全文

3

JCA

Original Research Article


3. Hypoxia-induced stabilization of HIF2A promotes cardiomyocyte proliferation by attenuating DNA damage
  • Correspondence: Prof. Shah R. Ali, Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, USA; Prof. Hesham A. Sadek, Department of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, USA.

  • How to cite: Ali S R, Nguyen N U N, Menendez-Montes I, Hsu CC, Elhelaly W, Lam NT, Li S, Elnwasany A, Nakada Y, Thet S, Foo RSY, Sadek HA. Hypoxia-induced stabilization of HIF2A promotes cardiomyocyte proliferation by attenuating DNA damage. J Cardiovasc Aging. 2024;4:11.

    http://dx.doi.org/10.20517/jca.2023.43

  识别二维码阅读英文全文


4. Long-term efficacy and safety of cardiac genome editing for catecholaminergic polymorphic ventricular tachycardia

  • Correspondence: Xander H. T. Wehrens, MD, PhD, Cardiovascular Research Institute, Baylor College of Medicine, USA.

  • How to cite: Moore OM, Aguilar-Sanchez Y, Lahiri SK, Hulsurkar MM, Navarro-Garcia JA, Word TA, Keefe JA, Barazi D, Munivez EM, Moore CT, Parthasarathy V, Davidson J, Lagor WR, Park SH, Bao G, Miyake CY, Wehrens XHT. Long-term efficacy and safety of cardiac genome editing for catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Aging. 2024;4:8.
    http://dx.doi.org/10.20517/jca.2023.42

识别二维码阅读英文全文


5. Microvascular angiotensin II type 2 receptor function is enhanced in young females and declines in a model of murine aging

  • Correspondence: Dr. Jennifer J. DuPont, Molecular Cardiology Research Institute, Tufts Medical Center, USA.

  • How to cite: Turner CG, de Oliveira K, Lu Q, Patel AR, Pulakat L, Jaffe IZ, DuPont JJ. Microvascular angiotensin II type 2 receptor function is enhanced in young females and declines in a model of murine aging. J Cardiovasc Aging. 2024;4:19. 

    http://dx.doi.org/10.20517/jca.2024.09

识别二维码阅读英文全文

6. The modified 6-chromanol SUL-238 protects against accelerated vascular aging in vascular smooth muscle Ercc1-deficient mice

  • Correspondence: Dr. Anton J. M. Roks, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, the Netherlands.

  • How to cite: Jüttner AA, Mohammadi Jouabadi S, van der Linden J, de Vries R, Barnhoorn S, Garrelds IM, Goos Y, van Veghel R, van der Pluijm I, Danser AHJ, Mastroberardino PG, van der Graaf AC, Swart DH, Henning RH, Visser JA, Krenning G, Roks AJM. The modified 6-chromanol SUL-238 protects against accelerated vascular aging in vascular smooth muscle Ercc1-deficient mice. J Cardiovasc Aging. 2024;4:20.

    http://dx.doi.org/10.20517/jca.2024.10

识别二维码阅读英文全文

4

JCA

Review Article


7. Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart

  • Correspondence: Prof. Junichi Sadoshima. Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers-New Jersey Medical School, USA.

  • How to cite: Zhai P, Sadoshima J. Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart. J Cardiovasc Aging. 2024;4:18.

    http://dx.doi.org/10.20517/jca.2024.06

   识别二维码阅读英文全文


8. Adipose tissue lymphocytes and obesity

  • Correspondence: Prof. Huaizhu Wu, Department of Medicine, Baylor College of Medicine, USA.

  • How to cite: Gao F, Litchfield B, Wu H. Adipose tissue lymphocytes and obesity. J Cardiovasc Aging. 2024;4:5.

    http://dx.doi.org/10.20517/jca.2023.38

识别二维码阅读英文全文


9. Molecular mechanisms underlying sarcopenia in heart failure

  • Correspondence: Dr. Cody A. Rutledge, Department of Medicine, Case Western Reserve University School of Medicine, USA.

  • How to cite: Rutledge CA. Molecular mechanisms underlying sarcopenia in heart failure. J Cardiovasc Aging. 2024;4:7.

    http://dx.doi.org/10.20517/jca.2023.40

识别二维码阅读英文全文


10. Regulators of clonal hematopoiesis and physiological consequences of this condition

  • Correspondence: Dr. Kenneth Walsh, Robert M. Berne Cardiovascular Research Center, Division of Cardiovascular Medicine, University of Virginia School of Medicine, USA.

  • How to cite: Park E, Evans MA, Walsh K. Regulators of clonal hematopoiesis and physiological consequences of this condition. J Cardiovasc Aging. 2024;4:3. 

    http://dx.doi.org/10.20517/jca.2023.39

识别二维码阅读英文全文

关于期刊

The Journal of Cardiovascular AgingJCA)是一本金色开放获取、严格同行评议的国际学术期刊,由国际欧亚科学院院士,北京大学人民医院胡大一教授担任荣誉主编,来自全球多个国家的60位杰出学者组成编委团队,于2021年正式上线。现已出版128篇高质量文章,欢迎广大学者免费阅读分享!



JCA旨在发表与衰老和心血管疾病各个方面有关的基础研究、转化研究及临床应用,包括临床试验、饮食、治疗、遗传学、表观遗传学、基因组学、干细胞、免疫学、炎症、细胞周期调节、衰老、信号通路和药理学等。致力于为作者提供一个快速、公平、友好的学术出版平台,衷心期待您的来稿!


出版优势

快速出版:同行评议由编委负责,从提交到做出首次决定平均时长18天

数据库收录:ESCI, Scopus, CNKI, CAS, Dimensions, Lens

透明出版:经同行评议的文章,公开审稿报告

联系我们

期刊主页:

https://www.oaepublish.com/jca

投稿地址:

https://oaemesas.com/login?JournalId=jca

联系我们:
editorialoffice@cardiovascularaging.com

扫码进“JCA学者交流群”


*本文内容由OAE编辑部整理



关于OAE

OAE Publishing Inc. (OAE出版公司)于2015年在美国洛杉矶成立,是一家极具 "学术生态思维和学术使命感 "的学术出版公司。公司创办国际学术期刊26本(学科覆盖生物、医学、环境、材料、化学、计算机等学科),材料学科旗舰期刊:Energy Materials IF11.8分,位于WOS材料学领域Q1区;肿瘤学科旗舰期刊Cancer Drug Resistance IF4.6分,位于WOS肿瘤学领域Q1区。更多信息请前往OAE官方网站:www.oaepublish.com 了解详情。

OAE开放科学
OAE是一家极具创新性出版公司,出版26本英文期刊,覆盖生物、医学、环境、材料、化学、计算机等学科。旗舰期刊:Energy Materials,IF11.8分,位于WOS材料领域Q1区。
 最新文章